Skip to main content
. 2009 Jan 30;10(Suppl 1):S18. doi: 10.1186/1471-2105-10-S1-S18

Table 2.

Design of simulation 3 for evaluation

Gene ID Treatment Group Control Group
1 Exon 5~N (0, 1) All exons ~N (1.5,1), correlated
Exon 6~N (0, 1)
Others ~N (2.5, 1), correlated
2 Exon 5~N (0, 1) All exons ~N (2.5,1), correlated
Exon 6~N (0, 1)
Others ~N (1.5, 1), correlated
3 Exon 5~N (2.5, 1) Exon 5~N (0, 1)
Exon 6~N (0, 1) Exon 6~N (1.5, 1)
Others ~N (2.5, 1), correlated Others ~N (1.5, 1), correlated
4 Exon 5~N (1.5, 1) Exon 5~N (0, 1)
Exon 6~N (0, 1) Exon 6~N (2.5, 1)
Others ~N (1.5, 1), correlated Others ~N (2.5, 1), correlated

The design of alternatively spliced exons is same with simulation 1, but the power of normal distribution is different between two sample groups to simulate the differential expression in gene level.

HHS Vulnerability Disclosure